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Abstract: Oligohydramnios is an ominous pregnant complication with high perinatal morbidity 
and mortality of 80%–90%, if it was observed in second trimester. However, there is no prom-
ising modality to cure it at that period. In this case, heparin therapy was successful in an early 
onset extreme oligohydramnios.
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Introduction
Early onset fetal growth restriction accompanied by severe oligohydramnios is 
an ominous pregnant complication with high perinatal morbidity and mortality of 
80%–90% if observed in second trimester (Barss et al 1984; Mercer and Brown 
1986). However, there is no promising modality to cure severe oligohydramnios 
during this period. In this case, heparin therapy was successful in a very early onset 
(28 gestational week) fetal growth restriction accompanied severe oligohydramnios 
(amniotic ﬂ  uid index 1 cm).
Case report
A 28-year-old woman with 27+5 gestational weeks (accordingly to her last regular 
menstruation and early ultrasound-estimated data at prenatal diagnosis) was referred to 
my clinic because of severe early onset fetal growth restriction with 5.3 cm of biparietal 
diameter (BPD) and severe oligohydramnios with amniotic ﬂ  uid index (AFI) 1.0 cm 
(less than 1 percentile) by ultrasound (examined 3 times by 3 different persons with 3D 
color Doppler machine) (GE 730 ATL HDI5000,3.5 Hz; Philips, Solingen, Germany). 
But she could not be clearly scanned for fetal normality without ﬂ  uid. She had no 
heat exposure, vaginal ﬂ  uid discharge, or fever during this pregnancy. Also there was 
no identiﬁ  able perceived cause such as maternal anemia, smoking status, obesity or 
diabetes, or hypertensive state. Her body mass index was only 0.21.
Her medical history showed that in the previous year she had a stillbirth because 
of severe oligohydramnios during the second – third trimester at 24 gestational weeks. 
There was no special data provided about the stillbirth. She was admitted to hospital. 
The laboratory data from routine tests showed that she had normal blood, liver, and 
kidney function. But there were no promising modalities to treat her severe oligohy-
dramnios accompanied by severe fetal growth restriction, based on updated guidelines 
(USA). In practice, I found that heparin could improve amnion in preeclamptic patients 
accompanied by hypercoagulable state and reduced amniotic ﬂ  uid with prophylactic 
dosage of heparin for prevention from thromboembolism.International Journal of General Medicine 2008:1 2
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The patient was informed above experience. She wanted 
to be tried for treatment with heparin. After giving writ-
ten, informed consent, she received 6250 units of unfrac-
tured heparin mixed in 5% glucose 500 ml intravenously 
daily. From 1st Biology and Pharmacy Limited Company, 
Shanghai. China, NO:070701, 12500U/2 ml, 100 mg in one 
ample). The patient was monitored by blood routine test, 
and coagulate state once a day. The fetal surveillance was 
performed by Doppler waveform analysis, biophysical proﬁ  le 
scoring twice a week, and cardiotocographic tracing twice a 
week. The results showed in the normal range except for the 
intra-uterine growth retardation.
Surprisingly and fortunately, on the third therapy day, the 
ultrasonography assessment showed that AFI increased to 
6.0 cm with biparietal diameter 5.3 cm without abnormality. 
The patient received heparin therapy continuously for one 
week under normal monitoring coagulation parameters. She 
was discharged with AFI 7.6 cm and BPD 6.0 cm with normal 
Doppler wave form analysis of umbilical vessel, mid-cerebral 
artery, ductus venosus, or uteroplacental vessels. She was 
followed up at clinics twice a month before 36 gestational 
weeks, once a week after the 36th week, and advised to 
hospitalize if the AFI decreased again. During follow-up, 
she was hospitalized twice and received 3125 units unfrac-
tured heparin mixed in 5% glucose 500 ml intravenously 
daily for a week because of oligohydramnios recurrence at 
32 gestational weeks and 35 gestational weeks, respectively. 
At 38+ gestational weeks, a normal female infant was born 
with weight of 1850 g, 10 Apgar score, and clear ﬂ  uid.
Discussion
Oligohydramnios is a common complication of pregnancy, 
accompanied by fetal growth restriction or other pregnancy-
related diseases. It is a major determinant of infant morbidity 
and mortality both in undeveloped countries and developing 
countries. It is particularly ominous to observe severe oli-
gohydramnios in the second trimester as perinatal mortality 
rates then approach 80%–90% (Barss et al 1984; Mercer and 
Brown 1986). When amniotic ﬂ  uid is absent, the perinatal 
loss rate is high at 90% (Moor et al 1989). The lethal nature of 
the severe forms of oligohydramnios is a result of pulmonary 
hypoplasia. Currently, obstetricians are looking for some 
treatment modalities such as maternal hydration, amnioinfu-
sion, transabdominal amniocentesis prior to induction labor, 
but whether routine antepartum or intrapartum treatment will 
improve outcome remains to be seen.
In this case, heparin treatment for preterm oligohydram-
nios was generally successful. The detail mechanisms need 
to be further studied. As we known, heparin can promote 
blood circulation and improve placental function by decreas-
ing platelet aggregation, increasing exogenous anticoagulant 
activity, inhibiting ﬁ  brin formation and deposition, and 
decreasing thrombosis in placentas. According to our cur-
rent study on the heparinase expression in preeclampsia and 
eclamptic placentas and several oligohydromnios placentas, 
we found that the expression of heparinase is stronger in 
these placentas than in normal placentas (Chu 2004, 2005, 
2007a, 2007b; Chu and Huang 2005; Chu and Liang 2007; 
Chu and Zhou 2007). This is one of the reasons why patients 
with oligohydromnios need heparin. It may be that over-
productions of heparinase in placenta broke endogenous 
heparin and reduced blood circulation, then reduce the glo-
merular ﬁ  ltration rate, therefore, fetal urine and lung liquid 
are reduced and the sources of amniotic ﬂ  uid decreased. 
However, the concentration of endogenous heparin has not 
been tested by now. Therefore, the mechanisms of heparin 
for oligohydromnios need to be further studied in multiple 
centers, in randomized control trials.
Otherwise, hydration might exert an increase of AFI in 
this case. Therefore, a large-sample trials need to be con-
ducted to test whether heparin can improve preterm oligohy-
dramnios successfully subcutaneously not intravenously.
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